Headerlogotextwithshieldsshadowed

2022 Course Schedule
Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology

Virtual Meeting

Tentative schedule — times subject to change

Monday, October 24, 2022

10:00 A.M.
Opening Remarks Rakesh K. Jain
10:10 A.M.
Tumor Microenvironment I: Angiogenesis and Vascular Function Rakesh K. Jain
11:05 A.M.
Q&A
11:20 A.M.
Break
12:00 P.M.
Tumor Microenvironment II: Vascular Normalization and Immunotherapy  Rakesh K. Jain
1:10 P.M.
Q&A
1:25 P.M.
Break
2:00 P.M.
Tumor Microenvironment III: Extracellular Matrix, Lymphatics and Metastasis Rakesh K. Jain
3:10 P.M.
Q&A
3:25 P.M.
Break
4:00 P.M.
Cancer Immunology and Immunotherapy Overview Arlene Sharpe
5:05 P.M.
Q&A
5:20 P.M.
Adjourn

Tuesday, October 25, 2022

10:00 A.M.
Fibroblast Heterogeneity in Solid Tumors: Implications for Pancreatic Cancer David Tuveson
11:05 A.M.
Q&A
11:20 A.M.
Break
12:00 P.M.
Setting in Motion Anti-tumor Immunity: Lessons from the Microenvironment George Coukos
1:05 P.M.
Q&A
1:20 P.M.
Break
1:50 P.M.
Determinants of Effective Cancer Immunotherapy in Humans Nir Hacohen
2:50 P.M.
Q&A
3:00 P.M.
Break
4:00 P.M.
Tissue-specificity of Myeloid-mediated T-cell Suppression in Solid Tumors Lisa M. Coussens
5:05 P.M.
Q&A
5:20 P.M.
Adjourn

Wednesday, October 26, 2022

10:00 A.M.
Using Cell Transfer to Remodel the Tumor Microenvironment Carl June
11:05 A.M.
Q&A
11:20 A.M.
Break
12:00 P.M.
The Role of the Gut and Tumor Microbiome in Cancer Jennifer Wargo
1:05 P.M.
Q&A
1:20 P.M.
Break
2:00 P.M.
Heterogeneity Through Space and Time Drives the Clinical Behavior of Medulloblastoma Michael D. Taylor
3:05 P.M.
Q&A
3:20 P.M.
Break
4:00 P.M.
Dissecting the Ecosystem of Glioma by Single-Cell Genomics Mario Suva
5:05 P.M.
Q&A
5:20 P.M.
Adjourn

Thursday, October 27, 2022

10:00 A.M.
Determinants of How Tumors Use Metabolism to Support Growth Matthew Vander Heiden
11:05 A.M.
Q&A
11:20 A.M.
Break
12:00 P.M.
Mechanisms of Malignant Progression Robert A. Weinberg
1:05 P.M.
Q&A
1:20 P.M.
Break
2:00 P.M.
Circadian clock and Tumor Metabolic Vulnerabilities Chi Van Dang
3:05 P.M.
Q&A
3:20 P.M.
Break
4:00 P.M.
Lessons from Clinical Trials of Targeted Therapies for Cancer George W. Sledge, Jr
5:05 P.M.
Q&A
5:20 P.M.
Summary and closing remarks Rakesh K. Jain